The Medicines Company
In David Einhorn's portfolio · Greenlight Capital
Ticker MDCO
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2020 | Sell | 0 | |
| Q4 2019 | Reduce 69% | 229,900 | 1.4% |
| Q3 2019 | No change | 731,600 | 2.6% |
| Q2 2019 | Reduce 23% | 731,600 | 2.0% |
| Q1 2019 | No change | 948,800 | 1.9% |
| Q4 2018 | No change | 948,800 | 1.3% |
| Q3 2018 | Reduce 5% | 948,800 | 1.2% |
| Q2 2018 | No change | 1,000,000 | 1.2% |
| Q1 2018 | No change | 1,000,000 | 0.8% |
| Q4 2017 | Buy | 1,000,000 | 0.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.